Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 2
1982 3
1984 1
1985 4
1986 2
1987 3
1988 3
1989 1
1990 6
1991 6
1992 5
1994 5
1995 7
1996 4
1997 7
1998 5
1999 4
2000 6
2001 9
2002 8
2003 6
2004 7
2005 13
2006 13
2007 13
2008 8
2009 15
2010 16
2011 12
2012 10
2013 25
2014 19
2015 19
2016 23
2017 21
2018 27
2019 22
2020 25
2021 37
2022 29
2023 21
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

431 results

Results by year

Filters applied: . Clear all
Page 1
Impending fracture: A difficult diagnosis.
Piccioli A, Spinelli MS, Maccauro G. Piccioli A, et al. Injury. 2014 Dec;45 Suppl 6:S138-41. doi: 10.1016/j.injury.2014.10.038. Epub 2014 Nov 4. Injury. 2014. PMID: 25457334 Review.
A method of discrimination for patients who need preventative treatment for a metastatic lesion has not yet been established. CONCLUSIONS: Current score systems consider variables like size, location and treatment response and are easy to remember. However, t …
A method of discrimination for patients who need preventative treatment for a metastatic lesion has not yet been established. …
The effects of metastatic lesion on the structural determinants of bone: Current clinical and experimental approaches.
Bailey S, Hackney D, Vashishth D, Alkalay RN. Bailey S, et al. Bone. 2020 Sep;138:115159. doi: 10.1016/j.bone.2019.115159. Epub 2019 Nov 21. Bone. 2020. PMID: 31759204 Free PMC article. Review.
Research has now shifted to developing unbiased data-driven tools that can predict risk of impending fractures and guide individualized treatment decisions. ...Engineering-based analyses are non-invasive with the capability to evaluate oncological treatments and predict
Research has now shifted to developing unbiased data-driven tools that can predict risk of impending fractures and guide individualiz …
Pituitary metastasis: From pathology to clinical and radiological considerations.
Kameda-Smith MM, Zhang E, Lannon M, Algird A, Reddy K, Lu JQ. Kameda-Smith MM, et al. J Clin Neurosci. 2021 Nov;93:231-240. doi: 10.1016/j.jocn.2021.09.016. Epub 2021 Sep 24. J Clin Neurosci. 2021. PMID: 34656254 Review.
Often identified in parallel with extensive disseminated disease, once diagnosed, the prognosis is generally poor, although survival is highly heterogeneous and dependent on the primary tumor histology. Within this anatomical region is also the observation of tumor-to-tumo …
Often identified in parallel with extensive disseminated disease, once diagnosed, the prognosis is generally poor, although survival is high …
Development and validation of a longitudinal soft-tissue metastatic lesion matching algorithm.
Santoro-Fernandes V, Huff D, Scarpelli ML, Perk TG, Albertini MR, Perlman S, Yip SSF, Jeraj R. Santoro-Fernandes V, et al. Phys Med Biol. 2021 Jul 30;66(15). doi: 10.1088/1361-6560/ac1457. Phys Med Biol. 2021. PMID: 34261045
The optimal dilation magnitude of 25 mm yielded almost a perfect matching accuracy of 0.98. No significant matching accuracy decrease was observed in the subset of patients with high lesion disease burden. In summary, lesion matching using our new algorithm was highly accu …
The optimal dilation magnitude of 25 mm yielded almost a perfect matching accuracy of 0.98. No significant matching accuracy decrease was …
Personalizing Therapy for Metastatic Prostate Cancer: The Role of Solid and Liquid Tumor Biopsies.
Friedlander TW, Pritchard CC, Beltran H. Friedlander TW, et al. Am Soc Clin Oncol Educ Book. 2017;37:358-369. doi: 10.1200/EDBK_175510. Am Soc Clin Oncol Educ Book. 2017. PMID: 28561699 Free article. Review.
Although biopsies of metastatic prostate cancer are rarely undertaken in the clinical setting, there is increasing interest in developing personalized approaches to therapy by taking into account the genetic and phenotypic changes in an individual tumor. Indeed, analysis of metas …
Although biopsies of metastatic prostate cancer are rarely undertaken in the clinical setting, there is increasing interest in developing pe …
Ancillary Tests in Breast Cytology: A Practical Guide.
Beca F, Schmitt FC. Beca F, et al. Acta Cytol. 2019;63(4):302-313. doi: 10.1159/000499697. Epub 2019 May 29. Acta Cytol. 2019. PMID: 31141801 Review.
The applications reviewed in this article include the primary diagnosis of a breast lesion, the identification of the breast as a primary source of a metastatic lesion, the evaluation of breast prognostic/predictive markers, and the tracking of tumor evolutio …
The applications reviewed in this article include the primary diagnosis of a breast lesion, the identification of the breast as a primary so …
Survival effects of primary and metastatic surgical treatment in metastatic small intestinal tumors: A propensity score-matching study.
Zhou Z, Ge H, Li Y, Wang D, Güngör C. Zhou Z, et al. PLoS One. 2022 Jun 24;17(6):e0270608. doi: 10.1371/journal.pone.0270608. eCollection 2022. PLoS One. 2022. PMID: 35749551 Free PMC article.
OBJECTIVE: To analyze the effects of primary tumor resection and metastatic lesion resection on the survival of metastatic small intestinal tumors. ...CONCLUSION: In these carefully selected patients, primary tumor resection and/or metastatic lesion re …
OBJECTIVE: To analyze the effects of primary tumor resection and metastatic lesion resection on the survival of metastatic sma …
Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studies.
Ma SC, Tang XR, Long LL, Bai X, Zhou JG, Duan ZJ, Wang J, Fu QJ, Zhu HB, Guo XJ, Zhang YP, Guo ZQ, Wu DH, Dong ZY. Ma SC, et al. Oncoimmunology. 2021 Apr 26;10(1):1909296. doi: 10.1080/2162402X.2021.1909296. Oncoimmunology. 2021. PMID: 33996262 Free PMC article. Clinical Trial.
Specifically, adrenal gland and brain metastases were identified as favorable predictors of atezolizumab treatment. The DSO model was developed in the discovery cohort to integrate the directive effect of the primary and metastatic lesion spectrum. Remarkably …
Specifically, adrenal gland and brain metastases were identified as favorable predictors of atezolizumab treatment. The DSO model was …
Clinical features and management of trophoblastic epithelioid tumors: A systematic review.
Gorun F, Tomescu L, Motoc A, Citu C, Sas I, Serban DM, Forga M, Citu IM, Gorun OM. Gorun F, et al. Medicine (Baltimore). 2022 Jul 29;101(30):e29934. doi: 10.1097/MD.0000000000029934. Medicine (Baltimore). 2022. PMID: 35905248 Free PMC article.
The only filter used was the English language. Eligibility/inclusion criteria: retrospective observational studies (case reports, case series) including full case description of epithelioid trophoblastic tumor lesions. ...On univariate and multivariate analyses, stage IV d …
The only filter used was the English language. Eligibility/inclusion criteria: retrospective observational studies (case reports, cas …
Where does radioimmunotherapy fit in the management of breast cancer?
Doddamane I, Butler R, Jhaveri A, Chung GG, Cheng D. Doddamane I, et al. Immunotherapy. 2013 Aug;5(8):895-904. doi: 10.2217/imt.13.78. Immunotherapy. 2013. PMID: 23902558 Review.
Metastatic breast cancer is a heterogeneous disease that has a variety of different clinical presentations, ranging from solitary metastatic lesion to diffuse and multiple organ involvement. The biological heterogeneity of metastatic breast cancer has led to its unp …
Metastatic breast cancer is a heterogeneous disease that has a variety of different clinical presentations, ranging from solitary metasta
431 results